Cargando…
bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: A historical cohort study
BACKGROUND: Programmed cell death (apoptosis) has been implicated in tumor development and may affect the metastatic potential of tumor cells. The role of bcl-2, a proto-oncogene that inhibits apoptosis, has been studied in several malignancies, including cutaneous melanoma (CM). The purpose of this...
Autores principales: | Espíndola, Marília B, Corleta, Oly C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478655/ https://www.ncbi.nlm.nih.gov/pubmed/18570663 http://dx.doi.org/10.1186/1477-7819-6-65 |
Ejemplares similares
-
Amelanotic metastatic cutaneous melanoma
por: Mendes, Marcela Sena Teixeira, et al.
Publicado: (2013) -
Metastatic Cutaneous Melanoma of the Gallbladder
por: Patel, Dhruvan, et al.
Publicado: (2017) -
Iatrogenic Biliary Strictures: Surgical Experience with 39 Patients
por: Rohde, Luiz, et al.
Publicado: (1997) -
Identification of four genes associated with cutaneous metastatic melanoma
por: Ji, Chen, et al.
Publicado: (2020) -
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)